1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cardiometabolic Drug News APRIL 2015

Cardiometabolic Drug News APRIL 2015

  • April 2015
  • -
  • Espicom Business Intelligence
  • -
  • 19 pages

Industry Trend Analysis - Mysimba Will Have Fewer Competitors But Sales Dampened By Safety Concerns
Industry Brief - Intarcia/Numab Collaborate To Develop Therapies In Multiple Indications
Industry Brief - Janssen Acquires XO1
Industry Brief - Cardio3 To Open Manufacturing Facility In Minnesota
Industry Brief - Saxenda Approved In Europe For Obesity
Industry Brief - First-In-Class Type II Diabetes Treatment Glyxambi Available In US Pharmacies
Industry Brief - NICE Draft Guidance Recommends Apixaban For VTE
Industry Brief - Jubilant Gains New US Product Approvals
Industry Brief - Brilinta Receives FDA Approval For New Administration Option
Industry Brief - ANI Acquires Flecainide From Teva
Industry Brief - CHMP Recommends Empagliflozin/Metformin HCl For Approval
Industry Brief - Health Canada Grants Priority Review For Novartis' LCZ696 In HFrEF
Industry Brief - Amgen Astellas BioPharma Seeks Japanese Approval For Evolocumab
Industry Brief - Acasti Granted Chinese Patent Covering Phospholipid Omega-3 Therapy
Industry Brief - Zafatek Approved In Japan For Type II Diabetes
Industry Brief - Opsumit Approved In Japan For PAH
Industry Brief - Consilient Launches Metformin Tablets In UK
Industry Brief - ANI Launches Propafenone In US
Industry Brief - Companies Gain US Amlodipine+Valsartan Approvals
Industry Brief - TMC Settles Bivalirudin Litigation With Sun
Industry Brief - Portola Reports Full Results From Positive Phase III ANNEXA-R Study
Industry Brief - Capricor Completes Enrolment Of Cenderitide Phase II Trial In HF
Industry Brief - AstraZeneca To Collaborate With Singapore Research Organisations In HF
Industry Brief - Mesoblast Granted Japanese Patent Covering MPCs For Cardiovascular Indications
Industry Brief - FDA Grants ODD To Selten's Tacrolimus For PAH
Industry Brief - Esperion's ETC-1002 Phase IIb Study Meets Primary Endpoint In Hypercholesterolaemia
Industry Brief - AstraZeneca/HSCI Enter Research Collaboration For Diabetes
Industry Brief - Amgen's Repatha In Combination With Statins Reduced LDL-C In High-Risk Japanese Patients
Industry Brief - Bayer Expands Collaboration With Broad Institute To Develop Therapies For CV Disease
Industry Brief - Vytorin Reduced Total CV Events More Than Simvastatin Alone In ACS Patients
Industry Brief - MedImmune/São Paulo Enter Research Collaboration In Brazil
Industry Brief - Brilinta Reduced Thrombotic CV Events In Patients With History Of MI
Industry Brief - DSMB Recommends Continuation Of C-Cure Phase III Trial
Industry Brief - CSHL/GSK To Develop Diabetes And Obesity Therapeutic
Industry Brief - Capricor Commences Enrolment In Study To Evaluate HF Drug-Delivery Patch
Industry Brief - Bendavia Did Not Achieve Significance In Primary Analysis Population
Industry Brief - ARCA Amends GENETIC-AF Phase IIb/III Trial Protocol To Increase Enrolment Rate
Industry Brief - Repatha+SoC Combination Superior Over SoC In Reducing CV Events
Industry Brief - La Jolla Initiates LJPC-501 Phase III Trial In CRH
Industry Brief - Sanofi Reports Top-Line Results From Lixisenatide Phase IIIb CV Outcomes Study
Industry Brief - Mast To Develop Vepoloxamer In Chronic HF
Industry Brief - Faster-Acting Insulin Aspart Achieves HbA1c Reduction Over NovoRapid In Phase IIIa Trials
Industry Brief - Oramed Enrols First Patient In Glucose Clamp Study For Oral Insulin

Table Of Contents

Cardiometabolic Drug News APRIL 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.